Dextromethorphan and guaifenesin use need to be monitored thoroughly in people with "lousy metabolizer" CYP2D6 enzyme degrees and clients who are sedated. This mixture medication incorporates a huge median poisonous dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these sufferers. 资助维基百科 外观 创建账号 登录 个人工具 创建账号 https://andersonrqkex.mpeblog.com/53983346/new-step-by-step-map-for-dextromethorphan-dxm-for-sale-in-europe